Actinium Announces Appointment of Mark Kubik, MBA as Chief Business Officer
Go back to Actinium Announces Appointment of Mark Kubik, MBA as Chief Business Officer| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 6.56 -0.5 (7.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.06 | 52 Week High | $3.50 | |||
| Open | $6.96 | 52 Week Low | $0.86 | |||
| Day High | $6.97 | P/E | N/A | |||
| Day Low | $6.47 | EPS | $-7.61 | |||
| Volume | 328,850 | |||||
